Search research articles
Contact Us
Filters
Showing results (21-30 of 88) with videos related to
Page
of 9
Sort By:
European Journal of Haematology
|
January 10, 2008
A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5
Lindy-Anne Korswagen, Marjan Huizing, Suat Simsek, et al.
European Journal of Internal Medicine
|
January 2, 2013
Thyroid hormones and erythrocyte indices in a cohort of euthyroid older subjects
Roger K Schindhelm, Edwin ten Boekel, Nathalie E Heima, et al.
Acta Diabetologica
|
April 28, 2012
Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications
Sjoerd F Bakker, Maarten E Tushuizen, Mary E von Blomberg, et al.
European Journal of Internal Medicine
|
April 27, 2013
Thyroid hormones and erythropoiesis: a complex relation?
Roger K Schindhelm, Edwin Ten Boekel, Nathalie E Heima, et al.
Expert Opinion on Drug Safety
|
October 22, 2020
Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs
Charlotte Höybye, Paolo Beck-Peccoz, Suat Simsek, et al.
Thrombosis Research
|
September 26, 2022
Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
Esther M Speksnijder, Lisa M Hessels, Linda Muusses, et al.
Journal of Geriatric Cardiology : JGC
|
April 14, 2020
Opportunistic screening for atrial fibrillation with a single lead device in geriatric patients
Lennaert Ar Zwart, René Wmm Jansen, Jacob H Ruiter, et al.
BMC Endocrine Disorders
|
December 13, 2019
No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
Paolo Beck-Peccoz, Charlotte Höybye, Robert D Murray, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
September 25, 2020
Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope<sup>®</sup>): data from the PATRO Adults study
Paolo Beck-Peccoz, Charlotte Höybye, Robert D Murray, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 8, 2007
Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects
Suat Simsek, Natalja M Basoski, Nathalie Bravenboer, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 88) with videos related to
Sort By:
Page
of 9
European Journal of Haematology
|
January 10, 2008
A novel mutation in a Turkish patient with Hermansky-Pudlak syndrome type 5
Lindy-Anne Korswagen, Marjan Huizing, Suat Simsek, et al.
European Journal of Internal Medicine
|
January 2, 2013
Thyroid hormones and erythrocyte indices in a cohort of euthyroid older subjects
Roger K Schindhelm, Edwin ten Boekel, Nathalie E Heima, et al.
Acta Diabetologica
|
April 28, 2012
Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications
Sjoerd F Bakker, Maarten E Tushuizen, Mary E von Blomberg, et al.
European Journal of Internal Medicine
|
April 27, 2013
Thyroid hormones and erythropoiesis: a complex relation?
Roger K Schindhelm, Edwin Ten Boekel, Nathalie E Heima, et al.
Expert Opinion on Drug Safety
|
October 22, 2020
Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs
Charlotte Höybye, Paolo Beck-Peccoz, Suat Simsek, et al.
Thrombosis Research
|
September 26, 2022
Validation of the YEARS algorithm and Wells' score with the age-adjusted cut-off to exclude pulmonary embolism in COVID-19 patients
Esther M Speksnijder, Lisa M Hessels, Linda Muusses, et al.
Journal of Geriatric Cardiology : JGC
|
April 14, 2020
Opportunistic screening for atrial fibrillation with a single lead device in geriatric patients
Lennaert Ar Zwart, René Wmm Jansen, Jacob H Ruiter, et al.
BMC Endocrine Disorders
|
December 13, 2019
No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
Paolo Beck-Peccoz, Charlotte Höybye, Robert D Murray, et al.
Therapeutic Advances in Endocrinology and Metabolism
|
September 25, 2020
Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope<sup>®</sup>): data from the PATRO Adults study
Paolo Beck-Peccoz, Charlotte Höybye, Robert D Murray, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 8, 2007
Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects
Suat Simsek, Natalja M Basoski, Nathalie Bravenboer, et al.
Page
of 9